Video

Ovarian Cancer Heroes 2020

Author(s):

CURE Media Group

Watch the entire Ovarian Cancer Heroes program right here!

Watch the entire Ovarian Cancer Heroes program right here!

Newsletter

Stay up to date on cancer updates, research and education

Subscribe Now!
Related Videos
Image of woman.
Dr. Alex Francoeur interviewing against a gray CURE background
Kristie L. Kahl and Dr. Debra Richardson
Related Content
Rendering of an ovary with a tumor
April 7th 2025

BELLA Clinical Trial Initiated in Platinum-Resistant Ovarian Cancer

Alex Biese
The BELLA phase 2 clinical trial of relacorilant plus nab-paclitaxel and Avastin among patients with platinum-resistant ovarian cancer has been launched.
cancer horizons logo: a white microphone on a navy blue background
March 11th 2024

Oncology Approvals, Psychological Outcomes for Survivors and an Ovarian Cancer Vaccine

Alex Biese Brielle Benyon
Last week we saw some FDA approvals come through, as well as research that explored the psychosocial outcomes of individuals who survived pediatric rhabdosarcoma.
Ovaries.
March 31st 2025

Relacorilant Plus Chemo Meets Primary Goal in Ovarian Cancer Trial

Spencer Feldman
The phase 3 trial showed relacorilant with chemotherapy improved progression-free and overall survival in platinum-resistant ovarian cancer.
Shannon Miller smiling at a podium while delivering the keynote address at the 2023 Extraordinary Healer event | Image credit: © ATA-GIRL PHOTOGRAPHY
May 4th 2023

Olympian Shares Her Cancer Experience: ‘Give Yourself Grace’

Brielle Benyon
Olympic gymnast, Shannon Miller, sat down with CURE® to discuss her experience with a rare type of ovarian cancer, and how her competitive mindset helped her through.
The phase 3 trial design evaluating IMNN-001 in newly diagnosed advanced ovarian cancer has been finalized: © Tada Images - stock.adobe.com
March 24th 2025

Phase 3 Study Design Finalized with FDA for IMNN-001 in Ovarian Cancer

Alex Biese
The phase 3 trial design evaluating IMNN-001 in newly diagnosed advanced ovarian cancer has been finalized among regulatory agencies.
Elahere shows consistent survival benefits in patients with folate receptor alpha-positive platinum-resistant ovarian cancer: ©mi_viri - stock.adobe.com.
March 17th 2025

Elahere Shows Consistent Survival Benefit in Ovarian Cancer Subset

Spencer Feldman
Elahere shows consistent survival benefits in patients with folate receptor alpha-positive platinum-resistant ovarian cancer in the MIRASOL trial.